Back

GLP-1 RA as first-line therapy to improve outcomes?

1 September 2024 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: The impact of obesity management on cardiovascular outcomes Obesity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Paolo Sbraccia

Tor Vergata University Hospital Polyclinic, Rome (Italy)

3 More presentations in this session

Presentation thumbnail
Metabolic bariatric surgery as first-line therapy to improve outcomes
Professor G. Fruhbeck (Pamplona, ES)
Slides Video
Presentation thumbnail
Lifestyle intervention in HFpEF with obesity to improve outcomes
Professor E. Van Craenenbroeck (Edegem, BE)
Slides Video
Presentation thumbnail
HFpEF patients with obesity and atrial fibrillation: role of exercise and ablation
Doctor S. Wernhart (Munich, DE)
Slides Video

Access the full session

Session thumbnail
The impact of obesity management on cardiovascular outcomes
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:15 CET
You may be interested in
thumbnail
Congress Presentation
SELECT and STEP-HFpEF: new horizons.
27 August 2022
thumbnail
Congress Presentation
Is weight loss the main reason incretins reduce cardiovascular risk?: pro
28 August 2026
thumbnail
Congress Presentation
Novel weight loss drugs: how much cardiovascular risk reduction can we achieve?
25 April 2024
thumbnail
Congress Presentation
Evidence for cardio-renal protection through weight reduction
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources